Incidence and Clinical Burden of Erythropoietin Hyporesponsiveness - a Retrospective Database Analysis

Clinical trial NCT05530291 · COMPLETED

Trial details

NCT number: NCT05530291
Sponsor: Astellas Pharma Global Development, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Kidney Disease

Start date: 2022-11-18
Primary completion: 2022-11-22
Enrollment: 85259

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.